WallStreetZenWallStreetZen

NASDAQ: INZY
Inozyme Pharma Inc Stock Ownership - Who owns Inozyme Pharma?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Inozyme Pharma Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Douglas A. TrecoCEO2024-04-027,523$6.94
$52.21kSell
Matthew WintonCOO2024-03-283,188$3.33
$10.62kBuy
Sanjay SubramanianSVP CFO2023-09-292,319$3.57
$8.28kBuy
Pivotal Bioventure Partners Fund I LPDirector2023-08-01119,048$4.80
$571.43kBuy
Pivotal Bioventure Partners Fund I LPDirector2023-08-01714,285$4.80
$3.43MBuy
Robert Lorne HopfnerDirector2023-08-01714,285$4.80
$3.43MBuy
Robert Lorne HopfnerDirector2023-08-01119,048$4.80
$571.43kBuy
Robert Lorne HopfnerDirector2023-05-12228,702$6.25
$1.43MBuy
Robert Lorne HopfnerDirector2023-05-11219,230$6.48
$1.42MBuy

1 of 1

INZY insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INZY insiders and whales buy or sell their stock.

INZY Shareholders

What type of owners hold Inozyme Pharma Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Robert Lorne Hopfner12.05%7,446,481$32.24MInsider
Adage Capital Partners GP LLC8.96%5,537,500$23.98MInstitution
Pivotal Bioventure Partners Investment Advisor LLC7.28%4,494,851$19.46MInstitution
Sofinnova Investments Inc6.93%4,280,308$18.53MInstitution
Longitude Capital Partners Iii LLC6.76%4,174,379$18.08MInsider
Rock Springs Capital Management LP5.96%3,681,174$15.94MInstitution
Samlyn Capital LLC5.46%3,372,558$14.60MInstitution
Eventide Asset Management LLC5.15%3,179,837$13.77MInstitution
Pivotal Bioventure Partners Fund I LP5.12%3,162,895$13.70MInsider
Blackrock Inc4.93%3,042,330$13.17MInstitution

1 of 3

INZY vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INZY54.64%45.36%Net BuyingNet Selling
NBTX19.67%0.00%
EPIX73.10%26.90%Net BuyingNet Buying
AKBA26.15%8.85%Net SellingNet Selling
GLUE24.82%75.18%
View Top Biotech Stocks

Inozyme Pharma Stock Ownership FAQ

Who owns Inozyme Pharma?

Inozyme Pharma (NASDAQ: INZY) is owned by 81.00% institutional shareholders, 67.25% Inozyme Pharma insiders, and 0.00% retail investors. Robert Lorne Hopfner is the largest individual Inozyme Pharma shareholder, owning 7.45M shares representing 12.05% of the company. Robert Lorne Hopfner's Inozyme Pharma shares are currently valued at $33.06M.

If you're new to stock investing, here's how to buy Inozyme Pharma stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.